The trading of traditional Chinese medicine has increased the daily limit of Panlong Pharmaceutical, the trading of traditional Chinese medicine has increased, Panlong Pharmaceutical has increased its daily limit, Xiangxue Pharmaceutical has increased by over 9%, and Kunyao Group, Weikang Pharmaceutical, Huasen Pharmaceutical and Xinguang Pharmaceutical have followed suit.Treasury futures rose by 0.30%, the 30-year main contract rose by 0.30%, and the 30-year main contract rose by 0.30%, a record high. The 10-year main contract rose by 0.12%, the 5-year main contract rose by 0.05% and the 2-year main contract rose by 0.02%.Many places have started issuing coupons to help the consumption of catering and cultural tourism. With the arrival of the peak consumption season at the end of the year, Beijing, Changzhou, Jiangsu, Xi 'an and other places have started a new round of issuing coupons to support the consumption fields such as catering and cultural tourism. Shanghai "Lepin Shanghai" food and beverage coupons were distributed in the first batch in the third round, and all four coupons were arranged at a 30% discount. The first round of 40 million food and beverage coupons were collected within 15 minutes. Consumer vouchers cover many fields and are distributed in rolling stages to meet the needs of different consumers. The data shows that the role of consumer vouchers in stimulating consumption has steadily increased, effectively boosting consumer confidence and driving the recovery of related industries. Experts believe that consumer vouchers can produce a multiplier effect and promote economic activities. At the same time, it is necessary to strengthen supervision, prevent violations, introduce social capital to participate in the issuance of consumer vouchers, and form a diversified development model. (Securities Times)
In the inter-bank market, the yield of the active 10-year treasury bond "24 Treasury Bond with Interest 11" dropped by 1bp to 1.815%. Wind data shows that compared with yield to maturity, a Chinese bond with the same term, it hit a record low.The negative spread of 10-year national debt between China and the United States has expanded to nearly 250BP, which is the largest in more than 22 years.FTSE China A50 index futures rose 1%.
Evergrande Group and others were resumed execution by 320 million yuan. According to the information of legal proceedings, on December 11th, Evergrande Group Co., Ltd. added two pieces of resumption execution information, with a total execution amount of more than 322 million yuan, involving construction project contract disputes. The executors also included Hefei Yuetai Commercial Operation Management Co., Ltd. and Evergrande Real Estate Group Co., Ltd., and the enforcement court was the Baohe District People's Court in Hefei.In response to Trump's tariff threat, some Canadian governors supported the "cut-off" of energy products to the United States. Canadian Prime Minister Trudeau and provincial governors held another meeting on December 11 local time to discuss the tariff threat of US President-elect Trump. After the meeting, Canadian Deputy Prime Minister and Minister of Finance Christia freeland told the media that "many governors strongly supported Canada to take strong countermeasures, and some of them took the initiative to list the key minerals and metals produced in their provinces and exported to the United States." Doug Ford, Governor of Ontario, Canada, said after the meeting that if the United States insists on imposing tariffs on Canada, Ontario will "cut off" the energy supply to the United States. He said, "We will cut off the energy supply to Michigan, New York and Wisconsin." Ford also believes that Canada needs to "prepare for the battle" and Trump's tariff will be "100%". (CCTV News)The trading of traditional Chinese medicine has increased the daily limit of Panlong Pharmaceutical, the trading of traditional Chinese medicine has increased, Panlong Pharmaceutical has increased its daily limit, Xiangxue Pharmaceutical has increased by over 9%, and Kunyao Group, Weikang Pharmaceutical, Huasen Pharmaceutical and Xinguang Pharmaceutical have followed suit.
Strategy guide 12-14
Strategy guide 12-14